Cargando…

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?

Detalles Bibliográficos
Autores principales:	Chaturvedula, Ayyappa, Calad‐Thomson, Stacie, Liu, Chao, Sale, Mark, Gattu, Nandu, Goyal, Navin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657004/ https://www.ncbi.nlm.nih.gov/pubmed/31006175 http://dx.doi.org/10.1002/psp4.12418

Ejemplares similares

Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020)

Time to Expect More From Pharmacometrics
por: Barrett, Jeffrey S.
Publicado: (2020)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020)

Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
por: Ding, Junjie, et al.
Publicado: (2020)

R and nlmixr as a gateway between statistics and pharmacometrics
por: Fidler, Matthew, et al.
Publicado: (2021)

Broader Implications of Modeling and Simulation (M&S) Tools in Pharmacotherapeutic Decisions: A Cautionary Optimism
por: Chaturvedula, Ayyappa, et al.
Publicado: (2020)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Variable or variate? A conundrum in pharmacometrics exposure–response models
por: Grisic, Ana‐Marija, et al.
Publicado: (2022)

Barriers to global pharmacometrics: educational challenges and opportunities across the globe
por: Michelet, Robin, et al.
Publicado: (2023)

Editorial: Embracing Scrutiny
por: Goehl, Thomas J.
Publicado: (2004)

Embracing complexity in sepsis
por: Schuurman, Alex R., et al.
Publicado: (2023)

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
por: Keshavarzi Arshadi, Arash, et al.
Publicado: (2020)

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

The Mathematical and Computational Sciences Special Interest Group of the International Society of Pharmacometrics
por: Moore, Helen
Publicado: (2019)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
por: Hennig, Stefanie, et al.
Publicado: (2019)

The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities
por: Kaibara, Atsunori, et al.
Publicado: (2022)

Embracing Green Computing in Molecular Phylogenetics
por: Kumar, Sudhir
Publicado: (2022)

Embracing complexity in Drosophila cancer models
por: Choutka, Courtney, et al.
Publicado: (2022)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction
por: Craig, M, et al.
Publicado: (2016)

Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019)

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)
por: Sinha, Vikram, et al.
Publicado: (2021)

Establishing a Multidisciplinary Framework to Study Drug‐Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate
por: Lesko, Lawrence J., et al.
Publicado: (2018)

On scientific understanding with artificial intelligence
por: Krenn, Mario, et al.
Publicado: (2022)

Faculty development program evaluation: a need to embrace complexity
por: Fernandez, Nicolas, et al.
Publicado: (2019)

A digital embrace to blunt the curve of COVID19 pandemic
por: Schwamm, Lee H., et al.
Publicado: (2020)

Post-2020 biodiversity targets need to embrace climate change
por: Arneth, Almut, et al.
Publicado: (2020)

Embracing the Unprecedented Pace of Change: Artificial Intelligence's Impact on Dentistry and Beyond
por: Turkkahraman, Hakan
Publicado: (2023)

Health Care Equity in the Use of Advanced Analytics and Artificial Intelligence Technologies in Primary Care
por: Clark, Cheryl R., et al.
Publicado: (2021)

Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy
por: Farasati Far, Bahareh
Publicado: (2023)

Embracing AI: The Imperative Tool for Echo Labs to Stay Ahead of the Curve
por: Vasile, Corina Maria, et al.
Publicado: (2023)

Artificial intelligence powers digital medicine
por: Fogel, Alexander L., et al.
Publicado: (2018)

Neuro-symbolic approaches in artificial intelligence
por: Hitzler, Pascal, et al.
Publicado: (2022)

Artificial intelligence in clinical dentistry: The potentially negative impacts and future actions
por: Huang, Yung-Kai, et al.
Publicado: (2022)

Embracing our responsibility to ensure trainee competency
por: Santen, Sally A., et al.
Publicado: (2023)

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rl7maue0ha9ktmirnln3ve7eh2